Cigna Investments’s NuVasive, Inc. NUVA Stock Holding History

Cigna Investments’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,796	Closed	-$213K	–	774
2018 Q3	$213K	Buy	+3,796	New	+$242K	0.02%	673

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cigna Investments's NUVA Position: Q4 2018 in Review

Cigna Investments sold out of NuVasive, Inc. (NUVA) in Q4 2018, closing a stake of 3,796 shares — an estimated $213K sold.

Cigna Investments first reported a position in NUVA in Q3 2018 and held it in 1 quarter. The position peaked at $213K in Q3 2018. 290 funds tracked by Wall St. Rank hold NUVA as of Q4 2018.

Cigna Investments reported no remaining NuVasive, Inc. position as of Q4 2018 after selling out during the quarter.
Cigna Investments sold 3,796 NuVasive, Inc. shares in Q4 2018, an estimated $213K.
Cigna Investments first reported a position in NuVasive, Inc. in Q3 2018 and held it in 1 quarter.
Cigna Investments's NuVasive, Inc. position peaked at $213K in Q3 2018.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2018.

Based on Cigna Investments's 13F filing for Q4 2018, filed 6 Feb 2019.